Unilabs - Thomas Lindahl appointed Chief Medical Officer

Geneva, 15 July 2024: Unilabs, a leading international provider of diagnostic services, has appointed Thomas Lindahl, MD PhD as its Chief Medical Officer. 

Thomas has been with Unilabs since 2019, most recently as the company’s Medical Director, Radiology. Prior to joining Unilabs, Thomas held several senior medical leadership roles in the Nordics and in Australia.

Thomas has international clinical diagnostic experience with medical licenses in the UK and Nordics.  He holds a medical specialist in Radiology certificate from the Karolinska University Hospital, Stockholm and a PhD from the Karolinska Institute, Stockholm in Oncology for breast cancer. 

“Thomas brings a wealth of experience to the Unilabs Executive from both our business and the wider medical industry. He has led international medical teams, leveraging technical innovations such as digital diagnostic subspeciality networks across geographies and AI implementation.Using his world-class knowledge and expertise, he will play a key role in delivering effective treatment decisions that empower people to better manage their health, every day, everywhere” said Marc Engel, Chief Executive Officer, Unilabs.

“I’m excited to join the Unilabs Executive and further progress my mission to advance healthcare through world-leading medical diagnostics,” said Thomas Lindahl. “Operational excellence and innovation are top priorities, and I am committed to enhancing diagnostic accuracy and care, supporting people to power health and maximise life.”